| Literature DB >> 35564355 |
Jennifer Crowe1, Daniel Rojas-Valverde2, Marianela Rojas-Garbanzo1, Randall Gutiérrez-Vargas2, José Alexis Ugalde-Ramírez2, José Pablo Ledezma-Rojas3, William Cabrera-Alpizar2, Minor Salazar-Salazar4, Rodrigo Mauricio-La Torre4, Lázara Valera-Amador5, Berna van Wendel de Joode1.
Abstract
The aim of this study was to evaluate heat exposure, dehydration, and kidney function in rice workers over the course of three months, in Guanacaste, Costa Rica. We collected biological and questionnaire data across a three-month-period in male field (n = 27) and other (n = 45) workers from a rice company where chronic kidney disease of unknown origin (CKDu) is endemic. We used stepwise forward regression to determine variables associated with estimated glomerular filtration rate eGFR at enrollment and/or change in eGFR, and Poisson regression to assess associations with incident kidney injury (IKI) over the course of three months. Participants were 20-62 years old (median = 40 in both groups). Dehydration was common (≥37%) in both groups, particularly among other workers at enrollment, but field workers were more exposed to heat and had higher workloads. Low eGFR (<60 mL/min/1.73 m2) was more prevalent in field workers at enrollment (19% vs. 4%) and follow-up (26% vs. 7%). Field workers experienced incident kidney injury (IKI) more frequently than other workers: 26% versus 2%, respectively. Age (β = -0.71, 95%CI: -1.1, -0.4), current position as a field worker (β = -2.75, 95%CI: -6.49, 0.99) and past work in construction (β = 3.8, 95%CI: -0.1, 7.6) were included in the multivariate regression model to explain eGFR at enrollment. The multivariate regression model for decreased in eGFR over three month included current field worker (β = -3.9, 95%CI: -8.2, 0.4), current smoking (β= -6.2, 95%CI: -13.7-1.3), dehydration (USG ≥ 1.025) at both visits (β= -3.19, 95%CI: -7.6, 1.2) and pain medication at follow-up (β= -3.2, 95%CI: -8.2, 1.95). Current fieldwork [IR (incidence rate) = 2.2, 95%CI 1.1, 5.8) and being diabetic (IR = 1.8, 95%CI 0.9, 3.6) were associated with IKI. Low eGFR was common in field workers from a rice company in Guanacaste, and being a field worker was a risk factor for IKI, consistent with the hypothesis that occupational heat exposure is a critical risk factor for CKDu in Mesoamerica.Entities:
Keywords: agricultural workers; chronic kidney disease; heat exposure; hydration; occupational
Mesh:
Year: 2022 PMID: 35564355 PMCID: PMC9100597 DOI: 10.3390/ijerph19094962
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Selection of study participants. Two women were employed, and one provided informed consent, but had incomplete samples at follow-up. Only men are included in the analysis and shown here.
Characteristics at enrollment, unless indicated otherwise, of field and other workers with complete data at 3-month follow-up (n = 72). (Variables differing for field and other workers at p ≤ 0.05 shown with asterisk).
| Variables | Field Workers (n = 27) | Other Workers (n = 45) | ||
|---|---|---|---|---|
| Median (IQR) | Median (IQR) | |||
| Age (years), median (IQR) | 42 (30–54) | 40 (34–49) | ||
| Education (years), median (IQR) | 6 (2–7) | 8 (6–9) | ||
| Current job (years), median (IQR) | 9 (4–12) | 10 (3–18) | ||
| Farmworker (years), median (IQR) | 11 (8–20) | 0 | ||
| n |
| n |
| |
| Loss-to-follow-up | 3 | 11% | 4 | 9% |
| Incomplete primary education * | 11 | 41% | 4 | 9% |
| Born in Costa Rica * | 15 | 56% | 44 | 98% |
| Married/living as married | 20 | 43% | 35 | 78% |
| Past work agricultural work at another company | 15 | 56% | 29 | 64% |
| Past work in sugarcane fields (cutter/irrigation/planter) * | 9 | 33% | 2 | 4% |
| Past work as a sugarcane cutter * | 8 | 30% | 1 | 2% |
| Past work in construction | 11 | 41% | 12 | 27% |
| Consumption of alcohol | 19 | 70% | 35 | 78% |
| Current smoker | 3 | 11% | 3 | 7% |
| High blood pressure | 6 | 22% | 9 | 20% |
| Diabetes | 6 | 22% | 4 | 9% |
| Urinary tract infection during (ever) | 3 | 11% | 10 | 22% |
| Chistate (ever) * | 16 | 59% | 37 | 82% |
| Obese (BMI ≥ 30) | 7 | 26% | 13 | 29% |
| Pain medication last week at enrollment (a) | 10 | 42% | 11 | 29% |
| NSAID last week at enrollment (a) | 3 | 13% | 5 | 13% |
| Pain medication last week at followup | 6 | 22% | 9 | 20% |
| NSAID last week at followup | 1 | 4% | 3 | 7% |
| Ever pesticide use (b) | 21 | 84% | 27 | 60% |
| Ever paraquat use (b) | 18 | 72% | 25 | 56% |
| Ever glyphosate use (b) | 15 | 60% | 19 | 42% |
| Ever fungicide use (b, c) | 3 | 12% | 8 | 18% |
| Dehydrated at (USG ≥ 1.025) enrollment * | 10 | 37% | 29 | 64% |
| Dehydrated (USG ≥ 1.025) at 3-month follow-up | 12 | 44% | 20 | 44% |
| Dehydrated at enrollment and 3-month follow-up | 7 | 26% | 18 | 40% |
| Proteinuria one plus or higher enrollment * | 2 | 7% | 12 | 27% |
| Proteinuria one plus or higher 3-month follow-up * | 8 | 30% | 4 | 9% |
| Hematuria (dipstick, traces or more) enrollment | 1 | 4% | 1 | 2% |
| Hematuria (dipstick, traces or more) at 3-month follow-up | 6 | 22% | 4 | 9% |
| >3 Erythrocytes (microscopic) (enrollment) (d) | 1 | 5% | 0 | 0% |
| >3 Erythrocytes (microscopic) at 3-month follow-up | 2 | 7% | 1 | 2% |
| >5 Leucocytes (microscopic) (enrollement) (d) | 0 | 0% | 0 | 0% |
| >5 Leucocytes (microscopic) 3-month follow-up | 0 | 0% | 0 | 0% |
| Casts (any) enrollment (d, e) | 3 | 13% | 2 | 5% |
| Casts (any) 3 month follow-up (e) | 1 | 4% | 0 | 0% |
| Crystals (any) enrollment (d, f) | 4 | 18% | 8 | 17% |
| Crystals (any) 3 month follow-up (f) | 2 | 7% | 6 | 13% |
| BUN: Creatinine ratio at enrollment >20 at enrollment | 17 | 63% | 33 | 73% |
| BUN: Creatinine ratio at enrollment >20 at follow-up * | 16 | 59% | 35 | 78% |
| S-Cr >1.25 mg/dL enrollment * | 11 | 41% | 5 | 11% |
| S-Cr > 1.25 mg/dL at followup * | 11 | 41% | 8 | 18% |
| eGFR < 60 enrollment | 5 | 19% | 2 | 4% |
| eGFR < 60 at 3-month follow-up * | 7 | 26% | 3 | 7% |
| eGFR < 60 at enrollment and 3-month follow-up * | 3 | 11% | 0 | 0% |
| eGFR < 90 at enrollment | 18 | 67% | 35 | 78% |
| eGFR < 90 at 3-month follow-up | 24 | 89% | 32 | 71% |
| eGFR < 90 at enrollment and 3-month follow-up | 16 | 59% | 28 | 62% |
| IKI 3 months follow-up * | 7 | 26% | 1 | 2% |
Note: * indicates variables differing for field and other workers at p ≤ 0.05; (a): Missing information for 3 field and 7 other worker at enrollment, percentages for enrollment are from total non-missing (n = 24 field workers/n = 38 other workers, (b): Missing information for pesticide application for 2 field workers at enrollment, percentages shown are from total non-missing (n = 25 field workers); (c): Carbamate, benomyl or lanate; (d): Missing information for 4 other (non-field) workers at enrollment, percentages shown are from total non-missing (n = 27 field workers/n = 41 other workers); (e): Casts: Field workers at enrollment: 1 erythrocyte & 2 hyaline; Follow-up: 1 hyaline/Other workers at enrollment: 2 erythrocyte/Follow-up: none; (f): Crystals: field workers at enrollment: 4 amorphous urate/Follow-up: 1 uric acid & 1 unspecified; Non-field workers at enrollment: 4 calcium oxalate, 2 amorphous urate & 1 both; Follow-up: 3 calcium oxalate, 1 amorphous urate, 1 triple phosphate, 1 unspecified.
Figure 2(a) WBGT from 7:00 am–12:50 pm during study days in March (enrollment) and May (follow-up) outdoors (usual shift 6:00 am–1:00 pm with workers eating lunch in the field under a roof at approximately noon) and indoors from 8:00 am to 2:50 pm (usual shift 8:00 am–5:00 pm). The Occupational Safety and Health Administration (OSHA) recommended limits for moderate work (28 °C), and heavy work (26 °C) in acclimatized workers is indicated by the red lines. Median WBGT were 30.9 °C and 32.0 °C outdoors in compared to 27.4 °C and 27.7 °C indoors. (b) Average WBGT by time in outdoor (blue) and indoor (green) conditions in March (baseline, dark blue and dark green) and May (follow-up, light blue and light green) are shown in figure b. The OSHA recommended limit for moderate work which applied to both field and other workers on some days (27.8 °C), is shown in orange, and the limit for heavy work, which applied to field workers on some days (26.1 °C), is shown in red.
Urine and serum measurements as continuous variables in field workers (n = 27) and other workers (n = 45) at baseline and follow-up. Significant differences between the mean of field and other workers (p ≤ 0.05) are marked with an asterisk.
| Variable | Field Workers (n = 27) | Other Workers (n = 45) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Min | p50 | Max | Mean | SD | Min | p50 | Max | |
| Urine specific gravity (µg/L) at enrollment * | 1.017 | 0.009 | 1.000 | 1.015 | 1.030 | 1.024 | 0.008 | 1.005 | 1.030 | 1.030 |
| Urine specific gravity (µg/L) at 3-month visit | 1.02 | 0.007 | 1.005 | 1.02 | 1.030 | 1.019 | 0.009 | 1.005 | 1.020 | 1.030 |
| Serum creatinine at enrollment (mg/dL) | 1.22 | 0.308 | 0.57 | 1.13 | 1.96 | 1.12 | 0.146 | 0.85 | 1.12 | 1.55 |
| Serum creatinine at 3-month visit (mg/dL) * | 1.35 | 0.392 | 0.89 | 1.18 | 2.37 | 1.12 | 0.139 | 0.85 | 1.13 | 1.46 |
| eGFR at enrollment (ml/min/1.73 m2) | 77.8 | 21.4 | 40.7 | 80.9 | 128.4 | 82.6 | 13.7 | 51.3 | 81.7 | 118.6 |
| eGFR at 3-month visit (ml/min/1.73 m2) * | 70.2 | 18.7 | 33.3 | 75.2 | 105.5 | 82.7 | 14.0 | 54.5 | 80.9 | 118.6 |
| Difference eGFR (3-month enrollment) | −7.6 | 23.4 | −55.7 | −9.3 | 43.4 | 0.02 | 13.5 | −25.8 | 0 | 43.6 |
| S-glucose at enrollment (mg/dL) (a) | 97.22 | 27.4 | 31.6 | 90 | 252.9 | 27.43 | 100.0 | 69.6 | 93.6 | 233.8 |
| S-glucose at at 3-month visit (mg/dL) (a) | 134.03 | 86.7 | 70.7 | 104.4 | 450.4 | 111.68 | 37.5 | 80 | 102.8 | 331.7 |
| S-urea N (BUN) at enrollment (mg/dL) | 27.63 | 9.5 | 5.5 | 25.6 | 41.5 | 27.91 | 7.0 | 14.9 | 27.3 | 45.7 |
| S-urea N (BUN) at 3-month visit (mg/dL) | 30.94 | 11.6 | 4.9 | 29.1 | 59.1 | 27.47 | 5.6 | 16.7 | 27.8 | 38.3 |
| BUN: Creatinine ratio at enrollment (mg/dL) | 23.0 | 6.7 | 5.3 | 22.8 | 37.6 | 25.1 | 6.6 | 11.5 | 24.4 | 43.9 |
| BUN: Creatinine ratio at 3-month visit (mg/dL) | 23.7 | 7.9 | 2.6 | 23.1 | 37.9 | 24.8 | 5.8 | 12.1 | 25.3 | 36.8 |
| S-uric acid at enrollment (mg/dL) | 5.84 | 1.8 | 1.33 | 6.01 | 8.81 | 5.67 | 1.1 | 3.16 | 5.45 | 8.61 |
| S-uric acid at 3-month visit (mg/dL) | 6.29 | 1.4 | 4.19 | 6.01 | 9.73 | 5.73 | 1.2 | 3.84 | 5.47 | 8.92 |
| S-albumin at enrollment (g/dL) | 4.31 | 1.0 | 1.67 | 4.42 | 5.99 | 4.48 | 0.2 | 4.05 | 4.46 | 4.92 |
| S-albumin at 3-month visit (g/dL) | 4.48 | 0.3 | 3.63 | 4.5 | 4.88 | 4.53 | 0.2 | 3.97 | 4.57 | 4.95 |
| S-CPK at enrollment (Ul/L) | 213.48 | 174.9 | 18 | 176 | 893 | 160.09 | 71.2 | 43 | 138 | 343 |
| S-CPK at 3-month visit (Ul/L) | 216.78 | 192.9 | 62 | 150 | 672 | 196.43 | 116.3 | 62 | 159.5 | 400 |
| S-Na at enrollment (mmol/L) | 141.08 | 7.8 | 104.7 | 142.8 | 149.6 | 143.50 | 4.4 | 137.6 | 142.1 | 153.5 |
| S-Na at 3-month visit (mmol/L) * | 139.05 | 4.2 | 130.85 | 139.58 | 147.93 | 143.84 | 4.0 | 134.39 | 144.39 | 149.9 |
| S-K at enrollment (mmol/L) | 3.96 | 0.5 | 2.84 | 3.9 | 5.05 | 4.11 | 0.4 | 2.96 | 4.06 | 5.01 |
| S-K at 3-month visit (mmol/L) | 4.05 | 0.4 | 3.16 | 4.1 | 4.75 | 4.37 | 0.4 | 3.15 | 4.46 | 4.95 |
| S-Cl at enrollment (mmol/L) | 98.28 | 3.1 | 92.52 | 98.5 | 106 | 99.59 | 3.8 | 91.24 | 100.17 | 107.7 |
| S-Cl at 3-month visit (mmol/L) | 97.26 | 3.9 | 88.32 | 97.66 | 102.82 | 98.51 | 2.6 | 91.74 | 98.92 | 104.61 |
| S-Ca at enrollment (mmol/L) * | 2.16 | 0.2 | 1.24 | 2.22 | 2.41 | 2.26 | 0.1 | 2.04 | 2.25 | 2.52 |
| S-Ca at 3-month visit (mmol/L) | 2.27 | 0.1 | 2.12 | 2.25 | 2.48 | 2.30 | 0.1 | 2.06 | 2.3 | 2.58 |
| S-Mg at enrollment (mmol/L) * | 0.77 | 0.1 | 0.44 | 0.79 | 0.94 | 0.92 | 0.1 | 0.61 | 0.94 | 1.12 |
| S-Mg at 3-month visit (mmol/L) | 0.81 | 0.1 | 0.51 | 0.8 | 1.07 | 0.82 | 0.1 | 0.58 | 0.81 | 1.28 |
(a) Not all of the samples were fasting samples due to workers’ schedules, so results should be interpreted with caution.
Multivariate stepwise regression model for eGFR at enrollment. The variables age, current field worker, and past work in construction were maintained in the model, including all participants with complete data at follow-up (n = 72), explaining 20% of variability in eGFR [Adjusted R-square (R2adj) = 0.20].
| Y | Term | Estimate |
| Lower 95% | Upper 95% |
|---|---|---|---|---|---|
| eGFR at enrollment | Intercept | 110.69 | <0.00 | 95.61 | 125.76 |
| Age (41 ± 10) | −0.71 | <0.00 | −1.06 | −0.36 | |
| Current field worker (38%) | −2.75 | 0.15 | −6.49 | 0.99 | |
| Past work in construction (32%) | 3.75 | 0.06 | −0.14 | 7.64 |
Multivariate regression model for change in eGFR (Month 3–baseline). The variables current fieldwork, current smoking, being dehydrated at both visits, and use of pain medication at 3-month visit were maintained in this model (R2adj = 0.07), including all workers (n = 72).
| Term | β Estimate Difference in eGFR Month 3-Baseline |
| Lower 95% | Upper 95% |
|---|---|---|---|---|
| Intercept | −11.78 | 0.01 | −19.93 | −3.62 |
| Current field worker (38%) | −3.9 | 0.07 | −8.19 | 0.4 |
| Current smoker (8%) | −6.2 | 0.1 | −13.72 | 1.31 |
| Dehydrated at both visits (USG ≥ 1.025) (35%) | −3.19 | 0.15 | −7.58 | 1.2 |
| Pain medication at follow up (21%) (a) | −3.15 | 0.22 | −8.24 | 1.95 |
(a) pain medication during the past week reported at follow-up.
Poisson regression for IKI (yes or no) over three months (variables differing for field and other workers at p ≤ 0.05 shown with asterisk).
| Variables | Exp(β) (=IR Estimate, 95%CI) |
| ||
|---|---|---|---|---|
| (Intercept) | 0.14 | 0.00 | 0.28 | <0.001 |
| Diabetes | 1.83 | 0.90 | 3.60 | 0.08 |
| Current field worker * | 2.22 | 1.08 | 5.81 | 0.05 |